Tumor cell markers in uveal melanoma

Area of Science:

• Ophthalmology
• Oncology
• Immunohistochemistry

Background:

• Intraocular melanoma is a rare malignancy with variable prognoses.
• Identifying reliable prognostic markers is crucial for patient management.

Purpose of the Study:

• To evaluate the expression of melanoma-associated antigens (HMB-45, NKI/C3, S-100) and oncoproteins (ras-p21, mutated Ha-ras, neu/erb-B2) in intraocular melanomas.
• To correlate these markers with clinical outcomes.

Main Methods:

• Archival tissue from 43 intraocular melanomas was analyzed using immunohistochemistry.
• Monoclonal antibodies against HMB-45, NKI/C3, S-100 protein, ras-p21, mutated Ha-ras, and neu/erb-B2 were employed.
• Statistical analysis, including the chi-squared test for trend, was used to assess correlations.

Main Results:

• HMB-45 and NKI/C3 showed consistent moderate to strong staining in all cases.
• Ras-p21 immunostaining was heterogeneous, particularly in epitheloid tumor cells.
• A trend towards worse prognosis was observed in spindle cell melanomas with neu/erb-B2 positivity.
• Significant correlations were found between S-100 reactivity, neu/erb-B2 amplification, and clinical outcome.

Conclusions:

• S-100 protein and neu/erb-B2 amplification are significant prognostic indicators in intraocular melanoma.
• These markers may contribute to improved risk stratification and personalized treatment strategies.